Costanza Lo Cascio
costanzalc.bsky.social
Costanza Lo Cascio
@costanzalc.bsky.social
Damon Runyon-St. Jude Fellow @DanaFarber.bsky.social @HarvardMed.bsky.social | Filbin Lab | Pediatric Neuro-Oncology | Runner | Tetris enthusiast.
Reposted by Costanza Lo Cascio
Thrilled to share our work with Mariella Filbin, Johannes Gojo and Carl Koschmann, now published in @cp-cancercell.bsky.social We present a translational approach identifying the PDGFRA inhibitor avapritinib as a novel targeted treatment for pHGG with PDGFRA alterations www.cell.com/cancer-cell/...
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
PDGFRA is commonly altered in pediatric HGG. Mayr et al. report that the PDGFRA/KIT inhibitor avapritinib demonstrates on-target activity, brain penetrance, and survival benefit in pre-clinical H3K27M...
www.cell.com
March 13, 2025 at 3:30 PM
Reposted by Costanza Lo Cascio
Now online! Safeguarding the future of biomedical science in the United States
Safeguarding the future of biomedical science in the United States
NIH’s abrupt decision to cap indirect cost reimbursement at 15% threatens the critical infrastructure supporting groundbreaking biomedical research in the United States. This policy jeopardizes America’s global leadership in science and medicine. Urgent…
dlvr.it
March 1, 2025 at 1:42 PM
Reposted by Costanza Lo Cascio
First 🦋 post! Very excited to share our lab's latest work exploring the shared and divergent aspects of human astrocyte development and glioblastoma. This effort spans many fields from developmental #glial biology to #stem cells and #tumor biology. rdcu.be/d5ADz A 🧵
Mapping the developmental trajectory of human astrocytes reveals divergence in glioblastoma
Nature Cell Biology - Sojka et al. analyse the transcriptomic and epigenomic landscape of human astrocyte maturation and identify an epigenetically regulated intermediate state associated with...
rdcu.be
January 8, 2025 at 5:13 PM